Pelthos Therapeutics Inc. (NYSE:PTHS) on Thursday announced the launch of Zelsuvmi (berdazimer) topical gel 10.3% for molluscum contagiosum (molluscum) in adults and pediatric patients one year of age ...
Podofilox 0.5%; topical gel. Apply twice daily every 12 hrs for 3 days, then discontinue for 4 days; may repeat if needed; max 4 treatment cycles. Use applicator with solution; may use applicator or ...
– The B-SIMPLE4 pivotal Phase 3 clinical study of berdazimer gel, 10.3% (SB206) is the largest interventional trial of molluscum contagiosum ("molluscum") (n=891)1 – – Company previously reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback